Skip to main content

Advertisement

SpringerLink
Log in

Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle

  • Review
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

The promise of the mouse model of cytomegalovirus (CMV) research lies in a cost effective way to obtain significant data in in vivo settings. Keeping that promise requires a high degree of equivalency in the human and mouse virus. While genomic structure and many common proteins suggest that this system is appropriate to develop and test concepts in an organismal context, areas of difference have not been evaluated. Here we show that the major immediate early protein 1 (IE1) in MCMV binds the repressor Daxx suggesting that it serves a function performed by pp71 in HCMV. A Daxx binding pp71 equivalent at M82 could not be identified for MCMV. Differences in the mouse and human interferon upregulation of Daxx may have driven the need to have a Daxx-defeating function during reactivation, when pp71 is not present. The major immediate early protein 1 also differs in its chromatin binding properties between the two viruses. MCMV IE1 does not bind to chromatin, but HCMV IE1 does. It remains unclear whether this difference is functionally significant. The HCMV major immediate early protein 2 and its MCMV equivalent IE3 differ in their effect on the cell cycle; HCMV IE2 blocks the cell cycle, but MCMV IE3 does not, allowing MCMV to spread in infected mouse cells by cell division with continued expression of the major transactivating viral proteins. Actively transcribing genomes inducing immediate transcript environments are usually silenced and diminish during cell cycle progression. However, a recognizable desilencing and increase in immediate transcript environments takes place immediately after mitosis in MCMV infected cells. This raises the possibility that desilencing happens during tissue transplantation, wound healing, or other injury where cells are induced to proliferate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Sanchez V, Spector DH (2006) Exploytation of host cell cycle regulatory pathways by HCMV. In: Reddehase MJ (ed) Cytomegaloviruses. Caister Academic Press, Norfolk, pp 205–230

  2. Tang Q, Maul GG (2006) Immediate-early interactions and epigenetic defense mechanisms. In: Reddehase MJ (ed) Cytomegaloviruses. Caister Academic Press, Norfolk, pp 131–150

  3. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF III, Maul GG (1999) PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147:221–234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ishov AM, Maul GG (1996) The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134:815–826

    Article  CAS  PubMed  Google Scholar 

  5. Ishov AM, Stenberg RM, Maul GG (1997) Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol 138:5–16

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kapasi AJ, Spector DH (2008) Inhibition of the cyclin-dependent kinases at the beginning of human cytomegalovirus infection specifically alters the levels and localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and cdk7 at the viral transcriptosome. J Virol 82:394–407

    Article  CAS  PubMed  Google Scholar 

  7. Tang Q, Maul GG (2003) Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. J Virol 77:1357–1367

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Saffert RT, Kalejta RF (2006) Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80:3863–3871

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tavalai N, Papior P, Rechter S, Leis M, Stamminger T (2006) Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80:8006–8018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lin DY, Huang YS, Jeng JC, Kuo HY, Chang CC, Chao TT, Ho CC, Chen YC, Lin TP, Fang HI et al (2006) Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell 24:341–354

    Article  CAS  PubMed  Google Scholar 

  11. Saffert RT, Kalejta RF (2007) Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol 81:9109–9120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cranmer LD, Clark CL, Morello CS, Farrell HE, Rawlinson WD, Spector DH (1996) Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins. J Virol 70:7929–7939

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tang Q, Maul GG (2006) Mouse cytomegalovirus crosses the species barrier with help from a few human cytomegalovirus proteins. J Virol 80:7510–7521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hollenbach AD, Sublett JE, McPherson CJ, Grosveld G (1999) The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. Embo J 18:3702–3711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Xu Y, Ahn JH, Cheng M, apRhys CM, Chiou CJ, Zong J, Matunis MJ, Hayward GS (2001) Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression. J Virol 75:10683–10695

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Johnson ES (2004) Protein modification by sumo. Annu Rev Biochem 73:355–382

    Article  CAS  PubMed  Google Scholar 

  17. Nevels M, Brune W, Shenk T (2004) SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication. J Virol 78:7803–7812

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Lee HR, Kim DJ, Lee JM, Choi CY, Ahn BY, Hayward GS, Ahn JH (2004) Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J Virol 78:6527–6542

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Tavalai N, Papior P, Rechter S, Stamminger T (2008) Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82:126–137

    Article  CAS  PubMed  Google Scholar 

  20. Ahn JH, Brignole EJ 3rd, Hayward GS (1998) Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol Cell Biol 18:4899–4913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Angulo A, Ghazal P, Messerle M (2000) The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J Virol 74:11129–11136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. White EA, Clark CL, Sanchez V, Spector DH (2004) Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J Virol 78:1817–1830

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Caswell R, Hagemeier C, Chiou CJ, Hayward G, Kouzarides T, Sinclair J (1993) The human cytomegalovirus 86 K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J Gen Virol 74(Pt 12):2691–2698

    Article  CAS  PubMed  Google Scholar 

  24. Hagemeier C, Walker S, Caswell R, Kouzarides T, Sinclair J (1992) The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J Virol 66:4452–4456

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lukac DM, Harel NY, Tanese N, Alwine JC (1997) TAF-like functions of human cytomegalovirus immediate-early proteins. J Virol 71:7227–7239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Malone CL, Vesole DH, Stinski MF (1990) Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins. J Virol 64:1498–1506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Messerle M, Buhler B, Keil GM, Koszinowski UH (1992) Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J Virol 66:27–36

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Buhler B, Keil GM, Weiland F, Koszinowski UH (1990) Characterization of the murine cytomegalovirus early transcription unit e1 that is induced by immediate-early proteins. J Virol 64:1907–1919

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ahn JH, Jang WJ, Hayward GS (1999) The human cytomegalovirus IE2 and UL112–113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J Virol 73:10458–10471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Petrik DT, Schmitt KP, Stinski MF (2007) The autoregulatory and transactivating functions of the human cytomegalovirus IE86 protein use independent mechanisms for promoter binding. J Virol 81:5807–5818

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Iwayama S, Yamamoto T, Furuya T, Kobayashi R, Ikuta K, Hirai K (1994) Intracellular localization and DNA-binding activity of a class of viral early phosphoproteins in human fibroblasts infected with human cytomegalovirus (Towne strain). J Gen Virol 75(Pt 12):3309–3318

    Article  CAS  PubMed  Google Scholar 

  32. Tang Q, Li L, Maul GG (2005) Mouse cytomegalovirus early M112/113 proteins control the repressive effect of IE3 on the major immediate-early promoter. J Virol 79:257–263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Sourvinos G, Tavalai N, Berndt A, Spandidos DA, Stamminger T (2007) Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. J Virol 81:10123–10136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Wiebusch L, Hagemeier C (1999) Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1). J Virol 73:9274–9283

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Murphy EA, Streblow DN, Nelson JA, Stinski MF (2000) The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol 74:7108–7118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Kurz SK, Reddehase MJ (1999) Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J Virol 73:8612–8622

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Reddehase MJ, Podlech J, Grzimek NK (2002) Mouse models of cytomegalovirus latency: overview. J Clin Virol 25(Suppl 2):S23–36

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The MCMV GFP IE1/3 and the MCMV GFP IE3 virus has been generated by Qiyi Tang and their characterization is in progress (Tang QY and Maul GG in preparation). Olga Vladimirova has performed most of the other unpublished experiments. Both their help is very much appreciated.

Author information

Authors and Affiliations

  1. The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA

    Gerd G. Maul & Dmitri Negorev

Authors
  1. Gerd G. Maul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dmitri Negorev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerd G. Maul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maul, G.G., Negorev, D. Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle. Med Microbiol Immunol 197, 241–249 (2008). https://doi.org/10.1007/s00430-008-0078-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-008-0078-1

Keywords

Search

Navigation